manufacturing: be very profitable for pharmaceutical companies

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents business activity
Weight: 0.67
, sector
Weight: 0.67
, market
Weight: 0.64
, industry
Weight: 0.61
Siblings chemical plant
Weight: 0.71
, factory
Weight: 0.66
, refining
Weight: 0.53
, automobile industry
Weight: 0.36
, banking industry
Weight: 0.35

Related properties

Property Similarity
be very profitable for pharmaceutical companies 1.00
be very profitable for companies 0.93
is profitable 0.84
be more effective than sector 0.78
be more effective than public sector 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.35
Rule weight: 0.66
Evidence weight: 0.68
Similarity weight: 0.78
Evidence: 0.64
Plausible(sector, be more effective than sector) ⋁
Evidence: 0.89
¬ Typical(manufacturing, be very profitable for pharmaceutical companies)
0.31
Rule weight: 0.66
Evidence weight: 0.61
Similarity weight: 0.77
Evidence: 0.57
Plausible(sector, be more effective than public sector) ⋁
Evidence: 0.89
¬ Typical(manufacturing, be very profitable for pharmaceutical companies)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.88
Similarity weight: 0.77
Evidence: 0.79
Plausible(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.57
¬ Plausible(sector, be more effective than public sector)
0.06
Rule weight: 0.09
Evidence weight: 0.86
Similarity weight: 0.78
Evidence: 0.79
Plausible(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.64
¬ Plausible(sector, be more effective than sector)

Remarkability exclusitivity betweem a parent and a child

0.29
Rule weight: 0.58
Evidence weight: 0.65
Similarity weight: 0.78
Evidence: 0.43
¬ Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.80
¬ Remarkable(sector, be more effective than sector)
0.29
Rule weight: 0.58
Evidence weight: 0.65
Similarity weight: 0.77
Evidence: 0.43
¬ Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.82
¬ Remarkable(sector, be more effective than public sector)

Remarkability from parent implausibility

0.27
Rule weight: 0.42
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.64
Plausible(sector, be more effective than sector) ⋁
Evidence: 0.43
Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.79
¬ Plausible(manufacturing, be very profitable for pharmaceutical companies)
0.26
Rule weight: 0.42
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.57
Plausible(sector, be more effective than public sector) ⋁
Evidence: 0.43
Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.79
¬ Plausible(manufacturing, be very profitable for pharmaceutical companies)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.79
Plausible(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.79
¬ Salient(manufacturing, be very profitable for pharmaceutical companies)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.93
Evidence: 0.89
Typical(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.86
¬ Typical(manufacturing, be very profitable for companies)
0.66
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.93
Evidence: 0.79
Plausible(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.79
¬ Plausible(manufacturing, be very profitable for companies)
0.66
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.93
Evidence: 0.79
Salient(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.84
¬ Salient(manufacturing, be very profitable for companies)
0.55
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.93
Evidence: 0.43
Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.56
¬ Remarkable(manufacturing, be very profitable for companies)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.79
Salient(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.89
¬ Typical(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.43
¬ Remarkable(manufacturing, be very profitable for pharmaceutical companies)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.79
Plausible(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.89
¬ Typical(manufacturing, be very profitable for pharmaceutical companies)

Typicality and Rermarkability incompatibility between a parent and a child

0.31
Rule weight: 0.51
Evidence weight: 0.79
Similarity weight: 0.77
Evidence: 0.43
¬ Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.49
¬ Typical(sector, be more effective than public sector)
0.30
Rule weight: 0.51
Evidence weight: 0.74
Similarity weight: 0.78
Evidence: 0.43
¬ Remarkable(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.59
¬ Typical(sector, be more effective than sector)

Typicality inheritance from parent to child

0.35
Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.89
Typical(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.49
¬ Typical(sector, be more effective than public sector)
0.35
Rule weight: 0.48
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.89
Typical(manufacturing, be very profitable for pharmaceutical companies) ⋁
Evidence: 0.59
¬ Typical(sector, be more effective than sector)